Figure 5 | Scientific Reports

Figure 5

From: Eriodictyol attenuates osteoarthritis progression through inhibiting inflammation via the PI3K/AKT/NF-κB signaling pathway

Figure 5

Effects of eriodictyol on IL-1β-induced PI3K and AKT expression. Chondrocytes were pretreated with eriodictyol (5, 10, 15 μM) 12 h before IL-1β (10 ng/ml) treatment. 30 min after IL-1β treatment, the cells were collected for western blot analysis. The values presented are the means ± SEM of three independent experiments. #p < 0.01 versus control group; **p < 0.01 versus IL-1β group.

Back to article page